Dosimetry, Safety, and Efficacy Study of [177Lu]Lu-XT771 in Patients With Recurrent Glioblastoma

Clinical trial NCT07648823 · RECRUITING

Trial details

NCT number: NCT07648823
Sponsor: Beijing Tiantan Hospital
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Recurrent Glioblastoma (WHO-Grade IV Glioma)Recurrent Glioblastoma Glioblastoma (GBM)Recurrent Glioblastoma IDH Wildtype

Start date: 2026-06-20
Primary completion: 2027-06-20
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.